108 related articles for article (PubMed ID: 2827472)
1. Supplemental fosfomycin and/or steroids that reduce cisplatin-induced nephrotoxicity.
Umeki S; Watanabe M; Yagi S; Soejima R
Am J Med Sci; 1988 Jan; 295(1):6-10. PubMed ID: 2827472
[TBL] [Abstract][Full Text] [Related]
2. Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity.
Umeki S; Tsukiyama K; Okimoto N; Soejima R
Am J Med Sci; 1989 Oct; 298(4):221-6. PubMed ID: 2552802
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancer.
Rojanasthien N; Kumsorn B; Atikachai B; Leotrakul S; Thongprasert S
Int J Clin Pharmacol Ther; 2001 Mar; 39(3):121-5. PubMed ID: 11396752
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels.
Hayashi M; Numaguchi M; Watabe H; Enomoto H; Yaoi Y
Acta Obstet Gynecol Scand; 1997 Jul; 76(6):590-5. PubMed ID: 9246969
[TBL] [Abstract][Full Text] [Related]
5. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
6. The effect of fosfomycin on nedaplatin-induced nephrotoxicity in rats.
Yoshiyama Y; Yamaguchi K; Matsuo K; Kurokawa M; Kanke M
J Infect Chemother; 2005 Feb; 11(1):14-7. PubMed ID: 15729482
[TBL] [Abstract][Full Text] [Related]
7. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Kumazawa J
Int J Urol; 1996 Sep; 3(5):343-7. PubMed ID: 8886909
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
Yogi S; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
12. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.
Yazaki T; Yoshiyama Y; Wong P; Beauchamp D; Kanke M
Biol Pharm Bull; 2002 Apr; 25(4):516-9. PubMed ID: 11995935
[TBL] [Abstract][Full Text] [Related]
16. [Anticancer chemotherapy containing cisplatin in patients with lung cancer and kidney function].
Wiela-Hojeńska A; Passowicz-Muszyńska E; Orzechowska-Juzwenko K; Jankowska R; Hurkacz M; Unolt J; Weryńska B; Gołecki M; Dyła T
Pol Arch Med Wewn; 2002 Feb; 107(2):135-40. PubMed ID: 12107968
[TBL] [Abstract][Full Text] [Related]
17. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
[TBL] [Abstract][Full Text] [Related]
18. [Effect of fosfomycin on cisplatin-induced renal tubular damage].
Itoh H; Watanabe A; Ooka T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):147-50. PubMed ID: 2297234
[No Abstract] [Full Text] [Related]
19. Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
Hayashi T; Watanabe Y; Kumano K; Kitayama R; Muratani T; Yasuda T; Saikawa I; Katahira J; Kumada T; Shimizu K
Antimicrob Agents Chemother; 1989 Apr; 33(4):513-8. PubMed ID: 2729945
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
